Semaglutide's larger numbers come with their own asterisk: stopping the drug tends to reverse the benefit
(31) The time at which someone starts a treatment for obesity can itself be correlated with mental health difficulties, and the effects of the medication on weight, whether this is a dramatic reduction in weight, or a disappointing lack of weight reduction, can also trigger changes in mental health. (32) Based on major long-term trials, including FLOW (chronic kidney disease), SELECT (obesity/cardiovascular disease without diabetes), and SUSTAIN-6 (type 2 diabetes), semaglutide has demonstrated significant benefits across the cardiovascular and renal systems
IGF-1 LR3 According to Roberts, there are currently no human studies specifically focused on the efficacy of IGF-1 LR3 for muscle growth
Underlying conditions unmasked by weight loss or metabolic changes Tirzepatide does not cause muscle pain in isolation
Adequate protein is also needed to maintain bone mass, physical function, and immune function